Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Bright Minds Biosciences Inc. Common Stock
DRUG | US
89.14
USD3.96
4.65%
DRUG | US
About Bright Minds Biosciences Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
14/04/2026
Close
89.14
Open
86.50
High
90.31
Low
85.53
Bright Minds Biosciences Inc. a biotechnology company develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C 5-HT2A and 5-HT2C/A for the treatment of epilepsy pain and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York New York.
View LessDRUG | US
Risk
52.8
Sharpe
2.82
Luna's Score
58/100
Recommendation
Hold
Luna says (DRUG | US)
What's Working
Positive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
55.2%1 month
52.8%3 months
55.3%6 months
68.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
47.53
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-0.07
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
627.51M
MarketCap(USD)
627.51M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-51.80
Short ratio
3.50
Short perc.
2.38
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
21.78
Range1M
24.11
Range3M
25.80
Volumes: Market Activity
Rel. volume
0.61
Price X volume
8.83M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.07 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 47.53 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 55.28 | - | Lower Risk |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 627.51M | - | Emerging |
